Jacques Colinge
Molecular Biology · 2003–2019
A researcher in the Science corpus: 6 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 73 citations into it
Whom Jacques Colinge trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts Jacques Colinge overall
Papers from Jacques Colinge's perspective
Ordered by how strongly the researchers Jacques Colinge trusts endorse each paper. Same corpus, a different order for every researcher.
- Biological sequence analysis
- KEGG for linking genomes to life and the environment (Nucleic Acids Res.)
- Current best practices in single‐cell RNA‐seq analysis: a tutorial (Molecular Systems Biology)
- Visualization and analysis of single-cell RNA-seq data by kernel-based similarity learning (Nature Methods)
- The Reactome Pathway Knowledgebase
- Normalization and variance stabilization of single-cell RNA-seq data using regularized negative binomial regression (Genome Biology)
- The Universal Protein Resource (UniProt): an expanding universe of protein information (Nucleic Acids Res.)
- Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation (Nucleic Acids Research)
- Droplet barcoding for single cell transcriptomics applied to embryonic stem cells (Cell)
- Hallmarks of cancer: the next generation. (Cell)
Their papers
- Gene essentiality and synthetic lethality in haploid human cells (2015) — 809 citations
- The CRAPome: a Contaminant Repository for Affinity Purification Mass Spectrometry Data (2013) — 1,597 citations
- An orthogonal proteomic-genomic screen identifies AIM2 as a cytoplasmic DNA sensor for the inflammasome (2009) — 1,118 citations
- OLAV: Towards high‐throughput tandem mass spectrometry data identification (2003) — 310 citations
- SingleCellSignalR: inference of intercellular networks from single-cell transcriptomics (2019) — 349 citations
- Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets. (2007) — 706 citations